Singleton Hospital is a general hospital in Sketty Lane, Swansea, Wales. It is managed by Swansea Bay University Health Board.

There are 550 beds in Singleton Hospital.

During the past decade, Singleton Hospital conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 13 clinical trials were completed, i.e. on average, 36.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 10 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Singleton Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 5 trials, followed by "University College, London" with 4 trials sponsored, "Swansea University" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "University of Birmingham" with 3 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Singleton Hospital" #1 collaborator was "Cancer Research UK" with 12 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Abertawe Bro Morgannwg University Health Board" with 3 trials as a collaborator, "Royal Marsden NHS Foundation Trust" with 2 trials as a collaborator and "Takeda" with 2 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Singleton Hospital" are "Breast Cancer" (11 trials), "Multiple Myeloma" (5 trials), "Colorectal Cancer" (2 trials), "Lymphoma" (2 trials) and "Myelodysplastic Syndrome" (2 trials). Many other conditions were trialed in "Singleton Hospital" in a lesser frequency.

Most popular intervention types in "Singleton Hospital" are "Drug" (49 trials), "Procedure" (10 trials), "Other" (7 trials), "Radiation" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "cyclophosphamide" (5 trials), "Cisplatin" (3 trials), "Olaparib" (3 trials) and "Radiotherapy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Singleton Hospital" are 46 trials for "All" genders, 17 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Singleton Hospital". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Singleton Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Singleton Hospital, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".